Back to search

McMaster University

A Health Technology Assessment of Medical Cannabis: Clinical and Economic Effectiveness for Chronic Non-Cancer Pain and Policy Relevant Evidence From Canada

Abstract

dc:description.abstract

Chronic non-cancer pain affects many Canadians and is commonly treated with opioids, despite well-known risks such as dependence and overdose. Medical cannabis is increasingly used as an alternative, but uncertainty remains about its effectiveness, safety, and economic value through three studies. The first study indicated that opioids and medical cannabis produced small, comparable reductions in pain relief. However, opioids were associated with higher rates of treatment discontinuation due to adverse events. In the second study, which took an economic lens, medical cannabis was found to be cost-neutral relative to opioids, with comparable quality of life. The third study showed that medical cannabis users differ meaningfully from non-medical and dual users, exhibiting more frequent but less problematic consumption patterns. Overall, the results of these three studies provided evidence to inform clinical decision-making and reimbursement policy regarding medical cannabis for chronic pain in Canada.

Degree

thesis:*
Department dc:contributor.department
Clinical Health Sciences (Health Research Methodology)
Year dc:date.issued
2026

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Jeddi Haron Mark
Advisor dc:contributor.advisor
  • Tarride, Jean-Eric

Rights

Language dc:language.iso
en

Identifiers

dc:identifier.*

Chain of custody

source
Harvested from
McMaster University
Base URL
macsphere.mcmaster.ca/server/oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
related terms
citation

Jeddi Haron Mark. A Health Technology Assessment of Medical Cannabis: Clinical and Economic Effectiveness for Chronic Non-Cancer Pain and Policy Relevant Evidence From Canada. 2026. https://hdl.handle.net/11375/33005